Atreca, Inc. Long-term assets (Other)

Long-term assets (Other) of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term assets (Other) growth rates and interactive chart. All other non-current assets that do not fit the categories above.


Highlights and Quick Summary

  • Long-term assets (Other) for the quarter ending September 30, 2022 was $3.15 Million (a -9.95% decrease compared to previous quarter)
  • Year-over-year quarterly Long-term assets (Other) decreased by -13.25%
  • Annual Long-term assets (Other) for 2021 was $3.63 Million (a 16.68% increase from previous year)
  • Annual Long-term assets (Other) for 2020 was $3.11 Million (a 2.81% increase from previous year)
  • Annual Long-term assets (Other) for 2019 was $3.03 Million (a 857.59% increase from previous year)
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term assets (Other) of Atreca, Inc.

Most recent Long-term assets (Other)of BCEL including historical data for past 10 years.

Interactive Chart of Long-term assets (Other) of Atreca, Inc.

Atreca, Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $3.15 $3.5 $3.54
2021 $3.63 $3.08 $2.85 $3.08 $3.63
2020 $3.11 $3.04 $2.93 $2.9 $3.11
2019 $3.03 $1.51 $0.97 $3.03
2018 $0.32 $0.32
2017 $0.34

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology